This is an index of side effect / adverse reaction reports (a.k.a. adverse event reports) related to Cancidas (Caspofungin) and submitted to the FDA during the sample period of about a year. The information is not vetted and should not be considered as verified clinical evidence.
Reports by Event Outcome
All Cases (127)
Death (71)
Life Threatening Events (20)
Reports by Reaction Type
Drug Ineffective (27),
Septic Shock (18),
Death (16),
Renal Failure Acute (15),
Drug Interaction (10),
Overdose (9),
Hepatic Failure (6),
Multiple Drug Overdose (6),
Hypersensitivity (5),
Hepatotoxicity (5),
Hypotension (5),
Respiratory Distress (5)
Below are a few examples of reports where side effects / adverse reactions may be related to Cancidas (Caspofungin). For a complete list or a specific selection of reports, please use the links above.
Possible Cancidas side effects in
Reported by a physician from France on 2012-08-23
Patient:
Reactions: Death, Cytolytic Hepatitis
Adverse event resulted in: death, hospitalization
Drug(s) suspected as cause:
Ambisome
Dosage: 250 mg, qd
Indication: Systemic Candida
Start date: 2012-04-08
End date: 2012-04-22
Cancidas
Dosage: 70 mg, qd
Start date: 2012-03-22
End date: 2012-04-08
Cancidas
Dosage: 70 mg, qd
Indication: Systemic Candida
Start date: 2012-04-20
End date: 2012-04-22
Tienam IV
Dosage: 500 mg, q6h
Indication: Septic Shock
Start date: 2012-04-18
End date: 2012-04-22
Other drugs received by patient: Magnesium Sulfate; Targocid; Nexium; Norepinephrine; Fosfomycin
Possible Cancidas side effects in
Reported by a pharmacist from United States on 2012-08-15
Patient:
Reactions: Blood Phosphorus Increased
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Cancidas
Other drugs received by patient: Ativan; Methotrexate; Mercaptopurine; Lithium Carbonate; Scopolamine; Bactrim; Melatonin; Clonidine; Prevacid; Norvasc; Marinol; Lovenox; Acetaminophen / Hydrocodone Bitartrate; Leucovorin Calcium; Potassium (Unspecified); Zofran; Morphine
Possible Cancidas side effects in
Reported by a consumer/non-health professional from Netherlands on 2012-08-15
Patient:
Reactions: Hyperkalaemia
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Cancidas
Dosage: 50 mg, qd
Start date: 2010-01-28
End date: 2010-02-16
Cancidas
Dosage: 70 mg, qd
Indication: Infection Prophylaxis
Start date: 2010-01-27
End date: 2010-01-27
Tacrolimus
Indication: Liver Transplant
Start date: 2009-05-25
End date: 2010-01-27
Tacrolimus
Indication: Immunosuppression
Start date: 2010-01-29
End date: 2010-03-09
Tacrolimus
Start date: 2010-03-10
End date: 2010-03-14
Tacrolimus
Start date: 2010-03-17
Vancomycin
Indication: Localised Intraabdominal Fluid Collection
Start date: 2010-01-26
End date: 2010-02-04
Vancomycin
Indication: Staphylococcal Infection
Other drugs received by patient: Norfloxacin; Esomeprazole; Albumin (Human); Methylprednisolone; Insulin; Ipratropium Bromide; Plasma Protein Fraction (Human); Plasma Protein Fraction (Human); Sulfamethoxazole and Trimethoprim; Mycophenolate Mofetil; Terlipressin; Insulin; Meropenem; Blood Cells, RED; Omeprazole; Omeprazole; Heparin; Insulin; Dextrose; Duovent; Ceftriaxone Sodium; Ursodiol; Methylprednisolone; Acyclovir; Duovent; Mycophenolate Mofetil; Esomeprazole; Magnesium Sulfate; Lactitol; Albumin (Human); Ampicillin; Norepinephrine; Tramadol Hydrochloride; Heparin
Possible Cancidas side effects in 15 year old female
Reported by a health professional (non-physician/pharmacist) from France on 2012-08-07
Patient: 15 year old female
Reactions: Overdose, Drug Interaction, Renal Failure Acute
Adverse event resulted in: death
Drug(s) suspected as cause:
Bactrim
Dosage: 1 df, three times per week
Indication: Prophylaxis
Start date: 2012-04-01
Cancidas
Dosage: unk
Start date: 2012-05-28
End date: 2012-05-30
Ciprofloxacin HCL
Dosage: unk
Start date: 2012-05-28
End date: 2012-06-04
Clavulanate Potassium
Dosage: 1 df, 3x/day
Start date: 2012-05-28
End date: 2012-06-04
Gentamicin
Dosage: unk
Start date: 2012-05-26
End date: 2012-05-30
Other drugs received by patient possibly interacting with the suspect drug:
Neoral
Dosage: 100 mg, 2x/day
Administration route: Oral
Start date: 2012-04-23
End date: 2012-05-31
Vancomycin HCL
Dosage: 1 g, 2x/day
Start date: 2012-05-22
End date: 2012-06-03
Vfend
Dosage: 200 mg, 2x/day
Indication: Bronchopulmonary Aspergillosis
Start date: 2012-05-14
End date: 2012-05-25
Vfend
Dosage: 200 mg, 2x/day
Administration route: Oral
End date: 2012-05-31
Other drugs received by patient: Colistin; Gentamicin; Neupogen
Possible Cancidas side effects in 15 year old female
Reported by a individual with unspecified qualification from Ireland on 2012-08-06
Patient: 15 year old female
Reactions: Nephropathy Toxic, Drug Interaction, Multiple Drug Overdose, Respiratory Distress, Renal Failure Acute
Adverse event resulted in: death, hospitalization
Drug(s) suspected as cause:
Cancidas
Dosage: ; iv
Indication: Bronchopulmonary Aspergillosis
Start date: 2012-05-28
End date: 2012-05-30
Cyclosporine
Dosage: 200 mg; ;po
Administration route: Oral
Indication: Aplasia
Start date: 2012-04-23
End date: 2012-05-31
Gentamicin
Dosage: 170 ug; ;iv
Indication: Bronchopulmonary Aspergillosis
Start date: 2012-05-26
End date: 2012-05-30
Ticarcillin Disodium / Clavulanate Potassium (Claventin / 00973701 / )
Dosage: ; iv
Indication: Bronchopulmonary Aspergillosis
Start date: 2012-05-28
End date: 2012-06-01
Trimethoprim + Sulfamethoxazole
Dosage: ; tid; iv
Indication: Prophylaxis
Start date: 2012-04-01
Vancomycin
Dosage: 2 gm; iv
Indication: Bronchopulmonary Aspergillosis
Start date: 2012-05-22
Voriconazole
Dosage: ; iv
Indication: Bronchopulmonary Aspergillosis
Start date: 2012-05-14
End date: 2012-05-31
Other drugs received by patient: Colistin; Atgam; Ciprofloxacin; Filgrastim
Possible Cancidas side effects in
Reported by a physician from United States on 2012-08-03
Patient:
Reactions: Drug Ineffective
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Cancidas
Indication: Oesophagitis
Cancidas
Indication: Oropharyngeal Candidiasis
Other drugs received by patient: Lamivudine; Abacavir Sulfate; Raltegravir; Sulfamethoxazole and Trimethoprim; Etravirine
Possible Cancidas side effects in 15 year old female
Reported by a health professional (non-physician/pharmacist) from France on 2012-08-01
Patient: 15 year old female
Reactions: Overdose, Drug Interaction, Renal Failure Acute
Adverse event resulted in: death
Drug(s) suspected as cause:
Bactrim
Dosage: 1 df, three times per week
Indication: Prophylaxis
Start date: 2012-04-01
Cancidas
Dosage: unk
Start date: 2012-05-28
End date: 2012-05-30
Ciprofloxacin HCL
Dosage: unk
Start date: 2012-05-28
End date: 2012-06-04
Clavulanate Potassium
Dosage: 1 df, 3x/day
Start date: 2012-05-28
End date: 2012-06-04
Other drugs received by patient possibly interacting with the suspect drug:
Gentamicin
Dosage: unk
Start date: 2012-05-26
End date: 2012-05-30
Neoral
Dosage: 100 mg, 2x/day
Administration route: Oral
Start date: 2012-04-23
End date: 2012-05-31
Vancomycin HCL
Dosage: 1 g, 2x/day
Start date: 2012-05-22
End date: 2012-06-03
Vfend
Dosage: 200 mg, 2x/day
Administration route: Oral
End date: 2012-05-31
Vfend
Dosage: 200 mg, 2x/day
Indication: Bronchopulmonary Aspergillosis
Start date: 2012-05-14
End date: 2012-05-25
Other drugs received by patient: Colistin; Neupogen; Gentamicin
Possible Cancidas side effects in
Reported by a physician from United States on 2012-08-01
Patient:
Reactions: Pneumonia Bacterial, Septic Shock
Adverse event resulted in: death, hospitalization
Drug(s) suspected as cause:
Cancidas
Other drugs received by patient: Voriconazole
Possible Cancidas side effects in
Reported by a health professional (non-physician/pharmacist) from France on 2012-08-01
Patient:
Reactions: Overdose, Renal Failure Acute
Adverse event resulted in: death
Drug(s) suspected as cause:
Bactrim
Dosage: 1 df, tiw
Indication: Bronchopulmonary Aspergillosis
Start date: 2012-04-01
Cancidas
Dosage: unk
Indication: Bronchopulmonary Aspergillosis
Start date: 2012-05-28
End date: 2012-05-30
Ciproflaxacin
Dosage: unk
Indication: Bronchopulmonary Aspergillosis
Start date: 2012-05-28
End date: 2012-06-04
Clavulanate Potassium
Dosage: 1 df, tid
Indication: Bronchopulmonary Aspergillosis
Start date: 2012-05-28
End date: 2012-06-04
Other drugs received by patient possibly interacting with the suspect drug:
Gentamicin
Dosage: unk
Indication: Bronchopulmonary Aspergillosis
Start date: 2012-05-26
End date: 2012-05-30
Neoral
Dosage: 100 mg, bid
Administration route: Oral
Start date: 2012-04-23
End date: 2012-05-31
Vancomycin
Dosage: 2250 mg, qd
Start date: 2012-05-01
End date: 2012-05-01
Vancomycin
Dosage: 2000 mg, qd
Indication: Bronchopulmonary Aspergillosis
Start date: 2012-05-22
End date: 2012-05-01
Vancomycin
Dosage: 1800 mg, qd
Start date: 2012-05-01
End date: 2012-06-03
Vfend
Dosage: 200 mg, bid
Administration route: Oral
Start date: 2012-05-26
End date: 2012-05-31
Vfend
Dosage: 200 mg, bid
Indication: Bronchopulmonary Aspergillosis
Start date: 2012-05-14
End date: 2012-05-25
Other drugs received by patient: Neupogen
Possible Cancidas side effects in female
Reported by a physician from France on 2012-07-27
Patient: female
Reactions: Face Oedema, Oedema Peripheral, Renal Failure Acute
Adverse event resulted in: death
Drug(s) suspected as cause:
Bactrim
Dosage: 1unit three times per week
Indication: Prophylaxis
Start date: 2012-04-01
Cancidas
Indication: Bronchopulmonary Aspergillosis
Start date: 2012-05-28
End date: 2012-05-30
Ciprofloxacin HCL
Indication: Product Used FOR Unknown Indication
Start date: 2012-05-28
End date: 2012-06-04
Clavulanate Potassium
Indication: Bronchopulmonary Aspergillosis
Start date: 2012-05-28
End date: 2012-06-01
Gentamicin
Indication: Bronchopulmonary Aspergillosis
Start date: 2012-05-26
End date: 2012-05-30
Neoral
Dosage: 100mg twice per day
Administration route: Oral
Indication: Aplasia
Start date: 2012-04-23
End date: 2012-05-31
Vancomycin
Dosage: 1g twice per day
Indication: Bronchopulmonary Aspergillosis
Start date: 2012-05-22
Vfend
Dosage: 200mg twice per day
Indication: Bronchopulmonary Aspergillosis
Start date: 2012-05-14
End date: 2012-05-31
Other drugs received by patient: Atgam; Colistine; Neupogen
Possible Cancidas side effects in female
Reported by a health professional (non-physician/pharmacist) from France on 2012-07-26
Patient: female
Reactions: Bronchopulmonary Aspergillosis, Hypersensitivity, Hepatic Failure, Drug Interaction, Respiratory Distress, Generalised Oedema, Immunosuppressant Drug Level Decreased, Renal Impairment, Bone Marrow Failure, Multiple Drug Overdose, Renal Failure Acute
Adverse event resulted in: death, hospitalization
Drug(s) suspected as cause:
Atgam
Dosage: 40 mg/kg, unk
Start date: 2012-04-25
End date: 2012-04-27
Atgam
Dosage: 40 mg/kg, unk
Start date: 2012-04-23
Bactrim
Dosage: 1 df, qw3
Indication: Prophylaxis
Start date: 2012-04-01
Cancidas
Start date: 2012-05-28
End date: 2012-05-30
Ciprofloxacin
Start date: 2012-05-28
End date: 2012-06-06
Clavulanate Potassium
Dosage: unk
Start date: 2012-06-04
Clavulanate Potassium
Dosage: 1 df, tid
Start date: 2012-05-28
End date: 2012-06-01
Other drugs received by patient possibly interacting with the suspect drug:
Gentamicin
Neoral
Dosage: 1 df, bid
Administration route: Oral
Start date: 2012-04-23
Vancomycin
Dosage: 1 g, bid
Start date: 2012-05-22
Vancomycin
Dosage: 2000 mg, unk
Start date: 2012-05-25
Vancomycin
Dosage: 1800 mg, unk
Start date: 2012-06-06
Vancomycin
Dosage: 2250 mg, unk
Start date: 2012-05-31
Vancomycin
Dosage: 2000 mg, unk
Start date: 2012-06-04
Vfend
Administration route: Oral
Vfend
Dosage: 1 df, bid
Indication: Bronchopulmonary Aspergillosis
Start date: 2012-05-14
End date: 2012-05-31
Other drugs received by patient: Colistin; Neupogen
Possible Cancidas side effects in
Reported by a health professional (non-physician/pharmacist) from France on 2012-07-26
Patient:
Reactions: Overdose, Renal Failure Acute
Adverse event resulted in: death
Drug(s) suspected as cause:
Bactrim
Dosage: 1 df, tiw
Indication: Bronchopulmonary Aspergillosis
Start date: 2012-04-01
Cancidas
Dosage: unk
Indication: Bronchopulmonary Aspergillosis
Start date: 2012-05-28
End date: 2012-05-30
Ciproflaxacin
Dosage: unk
Indication: Bronchopulmonary Aspergillosis
Start date: 2012-05-28
End date: 2012-06-04
Clavulanate Potassium
Dosage: 1 df, tid
Indication: Bronchopulmonary Aspergillosis
Start date: 2012-05-28
End date: 2012-06-04
Other drugs received by patient possibly interacting with the suspect drug:
Gentamicin
Dosage: unk
Indication: Bronchopulmonary Aspergillosis
Start date: 2012-05-26
End date: 2012-05-30
Neoral
Dosage: 100 mg, bid
Administration route: Oral
Start date: 2012-04-23
End date: 2012-05-31
Vancomycin
Dosage: 2250 mg, qd
Start date: 2012-05-01
End date: 2012-05-01
Vancomycin
Dosage: 1800 mg, qd
Start date: 2012-05-01
End date: 2012-06-03
Vancomycin
Dosage: 1000 mg, bid
Indication: Bronchopulmonary Aspergillosis
Start date: 2012-05-22
End date: 2012-05-01
Vfend
Dosage: 200 mg, bid
Start date: 2012-05-14
End date: 2012-05-31
Vfend
Dosage: 200 mg, bid
Indication: Bronchopulmonary Aspergillosis
Start date: 2012-05-14
End date: 2012-05-25
Other drugs received by patient: Neupogen
Possible Cancidas side effects in 15 year old female
Reported by a health professional (non-physician/pharmacist) from France on 2012-07-26
Patient: 15 year old female
Reactions: Drug Interaction, Multiple Drug Overdose, Renal Failure Acute
Adverse event resulted in: death
Drug(s) suspected as cause:
Cancidas
Dosage: iv
Indication: Bronchopulmonary Aspergillosis
Start date: 2012-05-28
End date: 2012-05-30
Ciprofloxacin
Indication: Product Used FOR Unknown Indication
Start date: 2012-05-28
End date: 2012-06-04
Cyclosporine
Dosage: 200 mg;po
Administration route: Oral
Indication: Aplasia
Start date: 2012-04-23
End date: 2012-05-31
Gentamicin
Dosage: 170 ug;iv
Indication: Bronchopulmonary Aspergillosis
Start date: 2012-05-26
End date: 2012-05-30
Ticarcillin Disodium / Clavulanate Potassium (Claventin / 00973701 / )
Dosage: iv
Indication: Bronchopulmonary Aspergillosis
Start date: 2012-05-28
End date: 2012-06-01
Trimethoprim + Sulfamethoxazole
Dosage: tid;iv
Indication: Prophylaxis
Start date: 2012-04-01
Vancomycin
Dosage: 2 gm;iv
Indication: Bronchopulmonary Aspergillosis
Start date: 2012-05-22
Voriconazole
Dosage: 400 mg;iv
Indication: Bronchopulmonary Aspergillosis
Start date: 2012-05-14
End date: 2012-05-31
Other drugs received by patient: Filgrastim; Colistin; Atgam
Possible Cancidas side effects in female
Reported by a health professional (non-physician/pharmacist) from France on 2012-07-26
Patient: female
Reactions: Bronchopulmonary Aspergillosis, Hypersensitivity, Drug Interaction, Hepatic Failure, Respiratory Distress, Generalised Oedema, Immunosuppressant Drug Level Decreased, Renal Impairment, Bone Marrow Failure, Multiple Drug Overdose, Renal Failure Acute
Adverse event resulted in: death, hospitalization
Drug(s) suspected as cause:
Atgam
Dosage: 40 mg/kg, unk
Start date: 2012-04-25
End date: 2012-04-27
Atgam
Dosage: 40 mg/kg, unk
Start date: 2012-04-23
Bactrim
Dosage: 1 df, qw3
Indication: Prophylaxis
Start date: 2012-04-01
Cancidas
Start date: 2012-05-28
End date: 2012-05-30
Ciproflaxacin
Start date: 2012-05-28
End date: 2012-06-06
Clavulanate Potassium
Dosage: 1 df, tid
Start date: 2012-05-28
End date: 2012-06-01
Clavulanate Potassium
Dosage: unk
Start date: 2012-06-04
Other drugs received by patient possibly interacting with the suspect drug:
Gentamicin
Neoral
Dosage: 1 df, bid
Administration route: Oral
Start date: 2012-04-23
Vancomycin
Dosage: 1 g, bid
Start date: 2012-05-22
Vancomycin
Dosage: 2250 mg, unk
Start date: 2012-05-31
Vancomycin
Dosage: 1800 mg, unk
Start date: 2012-06-06
Vancomycin
Dosage: 2000 mg, unk
Start date: 2012-06-04
Vancomycin
Dosage: 2000 mg, unk
Start date: 2012-05-25
Vfend
Administration route: Oral
Vfend
Dosage: 1 df, bid
Indication: Bronchopulmonary Aspergillosis
Start date: 2012-05-14
End date: 2012-05-31
Other drugs received by patient: Colistin; Neupogen
Possible Cancidas side effects in
Reported by a physician from United States on 2012-07-20
Patient:
Reactions: Pneumonia Bacterial, Septic Shock
Adverse event resulted in: death, hospitalization
Drug(s) suspected as cause:
Cancidas
Other drugs received by patient: Voriconazole
Possible Cancidas side effects in 15 year old female
Reported by a health professional (non-physician/pharmacist) from France on 2012-07-20
Patient: 15 year old female
Reactions: Overdose, Drug Interaction, Renal Failure Acute
Adverse event resulted in: death
Drug(s) suspected as cause:
Bactrim
Dosage: 1 df, three times per week
Indication: Prophylaxis
Start date: 2012-04-01
Cancidas
Dosage: unk
Start date: 2012-05-28
End date: 2012-05-30
Ciprofloxacin HCL
Dosage: unk
Start date: 2012-05-28
End date: 2012-06-04
Clavulanate Potassium
Dosage: 1 df, 3x/day
Start date: 2012-05-28
End date: 2012-06-04
Other drugs received by patient possibly interacting with the suspect drug:
Gentamicin
Dosage: unk
Start date: 2012-05-26
End date: 2012-05-30
Neoral
Dosage: 100 mg, 2x/day
Administration route: Oral
Start date: 2012-04-23
End date: 2012-05-31
Vancomycin
Dosage: 1 g, 2x/day
Start date: 2012-05-22
End date: 2012-06-03
Vfend
Dosage: 200 mg, 2x/day
Indication: Bronchopulmonary Aspergillosis
Start date: 2012-05-14
End date: 2012-05-25
Vfend
Dosage: 200 mg, 2x/day
Administration route: Oral
End date: 2012-05-31
Other drugs received by patient: Neupogen; Colistin; Gentamicin
Possible Cancidas side effects in female
Reported by a physician from France on 2012-07-20
Patient: female
Reactions: Face Oedema, Oedema Peripheral, Renal Failure Acute
Adverse event resulted in: death
Drug(s) suspected as cause:
Bactrim
Dosage: 1unit three times per week
Indication: Prophylaxis
Start date: 2012-04-01
Cancidas
Indication: Bronchopulmonary Aspergillosis
Start date: 2012-05-28
End date: 2012-05-30
Ciprofloxacin HCL
Indication: Product Used FOR Unknown Indication
Start date: 2012-05-28
End date: 2012-06-04
Clavulanate Potassium
Indication: Bronchopulmonary Aspergillosis
Start date: 2012-05-28
End date: 2012-06-01
Gentamicin
Indication: Bronchopulmonary Aspergillosis
Start date: 2012-05-26
End date: 2012-05-30
Neoral
Dosage: 100mg twice per day
Administration route: Oral
Indication: Aplasia
Start date: 2012-04-23
End date: 2012-05-31
Vancomycin
Dosage: 1g twice per day
Indication: Bronchopulmonary Aspergillosis
Start date: 2012-05-22
Vfend
Dosage: 200mg twice per day
Indication: Bronchopulmonary Aspergillosis
Start date: 2012-05-14
End date: 2012-05-31
Other drugs received by patient: Atgam; Colistine; Neupogen
Possible Cancidas side effects in 27 year old female
Reported by a individual with unspecified qualification from France on 2012-07-17
Patient: 27 year old female
Reactions: Anaphylactic Reaction
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Cancidas
Dosage: 70.00 mg
Indication: Candidiasis
Start date: 2012-02-10
End date: 2012-02-10
Foscavir
Dosage: intravenous (not otherwise specified)
Indication: Product Used FOR Unknown Indication
Start date: 2012-02-10
End date: 2012-02-10
Other drugs received by patient: Gaviscon; Truvada; Lederfoline( Lederfoline); Raltegravir (Raltegravir); Inexium (Inexium); Fluconazole; Diffu K (Diffu K); Bactrim; Primperan (Primperan); Rovalcyte (Rovalcyte)
Possible Cancidas side effects in female
Reported by a health professional (non-physician/pharmacist) from France on 2012-07-17
Patient: female
Reactions: Bronchopulmonary Aspergillosis, Hypersensitivity, Drug Interaction, Hepatic Failure, Generalised Oedema, Immunosuppressant Drug Level Decreased, Renal Impairment, Bone Marrow Failure, Multiple Drug Overdose, Renal Failure Acute
Adverse event resulted in: death
Drug(s) suspected as cause:
Atgam
Dosage: 40 mg/kg, unk
Start date: 2012-04-23
Atgam
Dosage: 40 mg/kg, unk
Start date: 2012-04-25
End date: 2012-04-27
Bactrim
Dosage: 1 df, qw3
Indication: Prophylaxis
Start date: 2012-04-01
Cancidas
Start date: 2012-05-28
End date: 2012-05-30
Ciprofloxacin
Start date: 2012-05-28
End date: 2012-06-06
Clavulanate Potassium
Dosage: 1 df, tid
Start date: 2012-05-28
End date: 2012-06-01
Clavulanate Potassium
Dosage: unk
Start date: 2012-06-04
Other drugs received by patient possibly interacting with the suspect drug:
Gentamicin
Neoral
Dosage: 1 df, bid
Administration route: Oral
Start date: 2012-04-23
Vancomycin
Dosage: 1 g, bid
Start date: 2012-05-22
Vancomycin
Dosage: 2000 mg, unk
Start date: 2012-05-25
Vancomycin
Dosage: 2250 mg, unk
Start date: 2012-05-31
Vancomycin
Dosage: 1800 mg, unk
Start date: 2012-06-06
Vancomycin
Dosage: 2000 mg, unk
Start date: 2012-06-04
Vfend
Administration route: Oral
Vfend
Dosage: 1 df, bid
Indication: Bronchopulmonary Aspergillosis
Start date: 2012-05-14
End date: 2012-05-31
Other drugs received by patient: Colistin; Neupogen
Possible Cancidas side effects in female
Reported by a health professional (non-physician/pharmacist) from France on 2012-07-16
Patient: female
Reactions: Bronchopulmonary Aspergillosis, Hypersensitivity, Drug Interaction, Hepatic Failure, Generalised Oedema, Immunosuppressant Drug Level Decreased, Renal Impairment, Bone Marrow Failure, Multiple Drug Overdose, Renal Failure Acute
Adverse event resulted in: death
Drug(s) suspected as cause:
Atgam
Dosage: 40 mg/kg, unk
Start date: 2012-04-23
Atgam
Dosage: 40 mg/kg, unk
Start date: 2012-04-25
End date: 2012-04-27
Bactrim
Dosage: 1 df, qw3
Indication: Prophylaxis
Start date: 2012-04-01
Cancidas
Start date: 2012-05-28
End date: 2012-05-30
Ciprofloxacin
Start date: 2012-05-28
End date: 2012-06-06
Clavulanate Potassium
Dosage: unk
Start date: 2012-06-04
Clavulanate Potassium
Dosage: 1 df, tid
Start date: 2012-05-28
End date: 2012-06-01
Other drugs received by patient possibly interacting with the suspect drug:
Gentamicin
Neoral
Dosage: 1 df, bid
Administration route: Oral
Start date: 2012-04-23
Vancomycin
Dosage: 1800 mg, unk
Start date: 2012-06-06
Vancomycin
Dosage: 2000 mg, unk
Start date: 2012-06-04
Vancomycin
Dosage: 2000 mg, unk
Start date: 2012-05-25
Vancomycin
Dosage: 2250 mg, unk
Start date: 2012-05-31
Vancomycin
Dosage: 1 g, bid
Start date: 2012-05-22
Vfend
Dosage: 1 df, bid
Indication: Bronchopulmonary Aspergillosis
Start date: 2012-05-14
End date: 2012-05-31
Vfend
Administration route: Oral
Other drugs received by patient: Colistin; Neupogen
Possible Cancidas side effects in 75 year old male
Reported by a physician from United States on 2012-07-02
Patient: 75 year old male
Reactions: Pneumonia Bacterial, Septic Shock
Adverse event resulted in: death, hospitalization
Drug(s) suspected as cause:
Cancidas
Other drugs received by patient: Voriconazole
Possible Cancidas side effects in female
Reported by a physician from Japan on 2012-06-19
Patient: female
Reactions: Respiratory Failure
Adverse event resulted in: death
Drug(s) suspected as cause:
Cancidas
Possible Cancidas side effects in male
Reported by a physician from France on 2012-06-14
Patient: male
Reactions: Drug Ineffective, Septic Shock
Adverse event resulted in: death
Drug(s) suspected as cause:
Cancidas
Possible Cancidas side effects in 69 year old male
Reported by a physician from Spain on 2012-06-14
Patient: 69 year old male
Reactions: Drug Resistance, Treatment Failure
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Cancidas
Indication: Candidiasis
Start date: 2009-06-26
End date: 2009-06-26
Cancidas
Start date: 2009-06-27
End date: 2009-07-25
Cancidas
Start date: 2009-08-01
End date: 2009-09-01
Possible Cancidas side effects in female
Reported by a physician from France on 2012-06-14
Patient: female
Reactions: Drug Ineffective, Septic Shock
Adverse event resulted in: death
Drug(s) suspected as cause:
Cancidas
Possible Cancidas side effects in male
Reported by a physician from France on 2012-06-14
Patient: male
Reactions: Drug Ineffective, Septic Shock
Adverse event resulted in: death
Drug(s) suspected as cause:
Cancidas
Possible Cancidas side effects in 14 year old male
Reported by a physician from Spain on 2012-06-04
Patient: 14 year old male
Reactions: Respiratory Disorder, Anaphylactic Reaction, Subcutaneous Emphysema, Acidosis, Pyrexia, Transaminases Increased, Weight Increased, Cardio-Respiratory Arrest, Hepatotoxicity, Simplex Virus Test Positive, Decubitus Ulcer, Graft Versus Host Disease in Skin, Pneumothorax, Intracranial Pressure Increased, Escherichia Sepsis, Bone Marrow Transplant, Clostridium Test Positive, Hypotension, Complications of Bone Marrow Transplant, Respiratory Distress, Aplasia, Renal Failure, Fungal Test Positive, Hypoproteinaemia, Bradycardia, Staphylococcus Test Positive
Adverse event resulted in: death
Drug(s) suspected as cause:
Cancidas
Dosage: iv
Indication: Aspergillosis
Start date: 2010-12-01
End date: 2011-03-01
Cancidas
Dosage: iv
Indication: Rhinitis
Start date: 2010-12-01
End date: 2011-03-01
Voriconazole
Dosage: iv
Indication: Prophylaxis
Other drugs received by patient: Cyclophosphamide; Amphotericin B (+) Cholesterol (+) Diste
Possible Cancidas side effects in male
Reported by a physician from France on 2012-06-01
Patient: male
Reactions: Death, Septic Shock
Adverse event resulted in: death
Drug(s) suspected as cause:
Cancidas
Possible Cancidas side effects in female
Reported by a physician from France on 2012-06-01
Patient: female
Reactions: Death, Septic Shock
Adverse event resulted in: death
Drug(s) suspected as cause:
Cancidas
Possible Cancidas side effects in male
Reported by a physician from France on 2012-06-01
Patient: male
Reactions: Death, Septic Shock
Adverse event resulted in: death
Drug(s) suspected as cause:
Cancidas
|
